abstract |
The invention discloses the application of a substituted diphenylamine compound represented by general formula I as an antitumor drug, For the definition of each substituent in the formula, see the description. The compound of the general formula I has good antitumor activity, especially excellent activity against human lung cancer A549, human leukemia HL-60 and the like. |